WELB:XETRA:XETRA-Amundi MSCI ACWI SRI PAB UCITS ETF DR USD Acc (USD)

ETF | Others |

Last Closing

USD 11.626

Change

-0.06 (-0.51)%

Market Cap

USD 0.08B

Volume

6.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.36 (+0.70%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.63%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.49%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.18 (+0.65%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.20 (+0.85%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.62 (+1.06%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-2.08 (-1.49%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.42 (+0.96%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.32 (+0.64%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-5.46 (-1.09%)

USD 80.38B

ETFs Containing WELB:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.15% 21% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.15% 20% F 26% F
Trailing 12 Months  
Capital Gain 10.32% 61% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.32% 60% D- 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.81% 59% D- 57% F
Dividend Return 5.81% 58% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.17% 69% C- 75% C
Risk Adjusted Return 71.07% 89% A- 89% A-
Market Capitalization 0.08B 31% F 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.